Health · Healthcare & Policy · 1 hr ago

South Korea revised Sanofi flu vaccine deal after 500,000-dose shortfall

South Korea revised Sanofi flu vaccine deal after 500,000-dose shortfall

Sanofi Korea fell short by 500,000 flu vaccine doses ahead of South Korea’s national vaccination program.

The program, known as NIP, provides flu shots through a national immunization scheme.

South Korea’s Disease Control and Prevention Agency revised its contract with Sanofi, reducing the agreed supply without imposing penalties.

The agency did not impose measures such as a bidding ban or late-delivery charges, according to the account.

This has led to allegations that Sanofi received preferential treatment.

The revised contract is the reported outcome; no further steps are specified.

1 source

Related